INSOMNIA CHRONIC
Clinical trials for INSOMNIA CHRONIC explained in plain language.
Never miss a new study
Get alerted when new INSOMNIA CHRONIC trials appear
Sign up with your email to follow new studies for INSOMNIA CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a smart home cure your insomnia and boost your brain?
Symptom relief Not yet recruitingThis study tests a smart home system that uses lights, sounds, and a phone app to deliver insomnia therapy to older adults at home. The goal is to improve sleep and thinking skills. 180 people aged 65 and older with insomnia will use either the smart system, a sleep app, or sleep…
Matched conditions: INSOMNIA CHRONIC
Phase: PHASE2 • Sponsor: Proactive Life Inc • Aim: Symptom relief
Last updated May 26, 2026 09:43 UTC
-
Sleep double trouble: early insomnia fix may boost CPAP success
Symptom relief Not yet recruitingThis study looks at people who have both sleep apnea and chronic insomnia. Everyone gets a CPAP machine, but half also start a digital insomnia program right away. The goal is to see if treating insomnia early helps them use CPAP more and improves their health. 120 adults aged 45…
Matched conditions: INSOMNIA CHRONIC
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated May 26, 2026 09:32 UTC
-
New study tests sleep therapy for the grieving
Symptom relief Not yet recruitingThis study looks at whether a brief behavioral therapy for insomnia (BBTI) can improve sleep in people who have lost a loved one and now have trouble sleeping. About 58 adults who have been grieving for at least 6 months and have insomnia will take part. They will either receive …
Matched conditions: INSOMNIA CHRONIC
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
New sleep aid APSTZD put to the test in Mid-Stage trial
Symptom relief Not yet recruitingThis study tests a new insomnia drug, APSTZD, to see if it helps people stay asleep. About 222 adults with chronic insomnia will receive either APSTZD, an active comparator, or a placebo for 6 weeks. The main goal is to measure how much time they spend awake after falling asleep,…
Matched conditions: INSOMNIA CHRONIC
Phase: PHASE2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC